Gilead Sciences, Inc. (GILD) Shares Sold by First Midwest Bank Trust Division – TrueBlueTribune

 In Business

First Midwest Bank Trust Division lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 19.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,872 shares of the biopharmaceutical company’s stock after selling 7,033 shares during the period. First Midwest Bank Trust Division’s holdings in Gilead Sciences were worth $2,043,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of GILD. Wilsey Asset Management Inc. raised its stake in shares of Gilead Sciences by 2.7% in the first quarter. Wilsey Asset Management Inc. now owns 117,603 shares of the biopharmaceutical company’s stock worth $8,028,000 after buying an additional 3,042 shares during the period. Lawson Kroeker Investment Management Inc. NE raised its stake in shares of Gilead Sciences by 24.0% in the first quarter. Lawson Kroeker Investment Management Inc. NE now owns 120,888 shares of the biopharmaceutical company’s stock worth $8,211,000 after buying an additional 23,395 shares during the period. Gulf International Bank UK Ltd raised its stake in shares of Gilead Sciences by 1.3% in the first quarter. Gulf International Bank UK Ltd now owns 412,082 shares of the biopharmaceutical company’s stock worth $27,988,000 after buying an additional 5,100 shares during the period. Nexus Investment Management Inc. raised its stake in shares of Gilead Sciences by 7.7% in the first quarter. Nexus Investment Management Inc. now owns 253,166 shares of the biopharmaceutical company’s stock worth $17,195,000 after buying an additional 18,150 shares during the period. Finally, ANTIPODES PARTNERS Ltd raised its stake in shares of Gilead Sciences by 23.4% in the first quarter. ANTIPODES PARTNERS Ltd now owns 781,418 shares of the biopharmaceutical company’s stock worth $55,629,000 after buying an additional 148,226 shares during the period. 74.02% of the stock is owned by institutional investors and hedge funds.

Gilead Sciences, Inc. (NASDAQ GILD) traded down 0.31% on Friday, hitting $73.79. The stock had a trading volume of 3,729,031 shares. The firm has a market cap of $96.36 billion, a price-to-earnings ratio of 8.01 and a beta of 1.21. The company’s 50-day moving average price is $72.97 and its 200 day moving average price is $68.86. Gilead Sciences, Inc. has a one year low of $63.76 and a one year high of $82.07.

Gilead Sciences (NASDAQ:GILD) last released its quarterly earnings data on Wednesday, July 26th. The biopharmaceutical company reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.11 by $0.45. The company had revenue of $7.14 billion during the quarter, compared to analyst estimates of $6.35 billion. Gilead Sciences had a net margin of 42.90% and a return on equity of 66.07%. Gilead Sciences’s revenue for the quarter was down 8.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.08 EPS. Analysts expect that Gilead Sciences, Inc. will post $8.74 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Stockholders of record on Friday, September 15th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $2.08 annualized dividend and a dividend yield of 2.82%. Gilead Sciences’s dividend payout ratio is currently 22.58%.

TRADEMARK VIOLATION WARNING: This story was first reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.truebluetribune.com/2017/08/27/gilead-sciences-inc-gild-shares-sold-by-first-midwest-bank-trust-division.html.

Recent Posts
Get Breaking News Delivered to Your Inbox
Join over 2.3 million subscribers. Get daily breaking news directly to your inbox as they happen.
Your Information will never be shared with any third party.
Get Latest News in Facebook
Never miss another breaking news. Click on the "LIKE" button below now!